According to sources of FastCompany.com, government officials with stakes in the BPA industry may have a hand in the deregulation. In a report by the Milwaukee Journal Sentinel, a scientist, Martin Philbert, who was supervising the FDA's latest review had failed to disclose a $5 million donation from Charles Gelman, a retired medical device executive and staunch opponent of BPA control.
The industrial chemical BPA has just been cited as one of many causes of male infertility. Others include alcohol, fluoride, pesticides, and heavy metal, notes Chougule. (Related: Sperm counts continue to plummet, say researchers)
Alternative therapies as a solution to male infertility
There exist treatments for male infertility that, in spite of their efficacy, are frowned upon by the government and medical science. “Part of the reason may be that the most promising therapies for male infertility appear to be in the realm of alternative rather than allopathic medicine,” states Chougule.
Over the course of two decades, treatments such as acupuncture and moxibustion have been shown to increase sperm quality. Clinical studies have also demonstrated the potency of herbology in both male and female infertility cases. Under the Dietary Supplement Health and Education Act of 1994, however, it would be illegal to claim the supplements utilized in this practices “treat or prevent illness.”
Male infertility is seen as a symptom of systemic imbalances among alternative medical practitioners; they believe that asymmetry in the emotional and physical well-being among patients can bring about negative effects in the human body. A 2002 study has exposed a link between sperm quality and occupational psychological stress, psychological stress, and “potential reproductive toxic agents.”
By contrast, allopathic or mainstream medicine views male infertility as “an obstruction of the reproductive ductal system.” Correcting this can be done through insemination, in vitro fertilization or intracytoplasmic sperm injections, procedures that do not improve sperm quality or address the cause of sperm decline.
Where do we go from here?
It may be too soon to tell where the issue regarding male infertility will go. Under the current administration, it could go both ways. There have been moves to diminish the power the FDA has over chemical industries; on the other hand, this could also lead to the eventual reduction of industry influence on government investigations into male infertility. Whichever direction the government may take, it would be best to look to outside sources for possible treatments and more information on this issue.
You can learn more about medical and health issues by visiting MindBodyScience.news.
Sources include:
Please contact us for more information.
